AUGX AUGMEDIX INC

Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023

Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023

SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) --  (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the conference call will be available on the “Events” section of the Company’s website at: . Alternatively, interested parties can dial 877-407-3982 (toll-free) or 201-493-6780 (international) to listen. The webcast will be archived and available for replay after the event.

About Augmedix

Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.

Augmedix is on a mission to help clinicians and patients form a human connection by seamlessly integrating our technology at the point of care. Augmedix’s proprietary platform digitizes the natural clinician-patient conversations, which are converted into comprehensive medical notes and structured data in real time. The company’s platform uses automatic speech recognition, and natural language processing, including large language models, to generate accurate and timely medical notes that are transferred into the EHR.

Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout, increasing clinician efficiency and improving patient access. Through Augmedix’s proprietary platform and bi-directional communication channel, Augmedix is ideally suited to serve as the vehicle for change at the point of care.

Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit .

Contact Information

Investors:

Matt Chesler, CFA

FNK IR

(646) 809-2183



Media:

Kaila Grafeman

Augmedix



EN
30/10/2023

Underlying

AUGXAUGMEDIX INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AUGMEDIX INC

 PRESS RELEASE
Free
AUGX AUGMEDIX INC

Commure Completes Merger with Augmedix

Commure Completes Merger with Augmedix SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix’s special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior...

October 2, 2024 1 EN
 PRESS RELEASE
Free
AUGX AUGMEDIX INC

Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024

Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024 SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended June 30, 2024. “We believe we are approaching the proposed combination with Commure, Inc. from a position of strength, with consistent double-digit revenue growth and improving gross margins,” commented Manny Krakaris, Augmedix CEO. “Together, we believe we will be well-positioned to continue to streamline the medical documentati...

August 12, 2024 1 EN
 PRESS RELEASE
Free
AUGX AUGMEDIX INC

Augmedix to Announce Second Quarter 2024 Financial Results on August 1...

Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024 SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call. A...

August 6, 2024 1 EN
 PRESS RELEASE
Free
AUGX AUGMEDIX INC

Augmedix to Join Forces with Commure

Augmedix to Join Forces with Commure Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. ...

July 19, 2024 1 EN
 PRESS RELEASE
Free
AUGX AUGMEDIX INC

Emergency Services Inc. Partners with Augmedix to Introduce Generative...

Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments Emergency Services Inc. introduces Augmedix Go ED to central Ohio emergency departments to automate medical documentation SAN FRANCISCO, June 20, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that , a physician-owned emergency medicine services group in Columbus, Ohio, is introducing Augmedix Go ED to physicians in the emergency department (ED) at the second-largest healthc...

June 20, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch